Ambu A/S
AMBBYOTCHealthcare● Active
$9.98
$-0.19(-1.82%)
Market Cap$2.6B
P/E Ratio—
52W High$16.78
52W Low$9.575
Ambu A/S（AMBBY）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AMBBY · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $5.69B | $5.39B | $4.78B | $4.44B | $4.01B |
| Cost of Revenue | $2.50B | $2.19B | $2.06B | $1.89B | $1.51B |
| Gross Profit | $3.18B | $3.20B | $2.71B | $2.55B | $2.50B |
| Gross Margin %(computed) | 55.98% | 59.38% | 56.82% | 57.47% | 62.37% |
| Operating Expenses | |||||
| R&D Expenses | $0.13B | $0.33B | $0.29B | $0.28B | $0.23B |
| G&A Expenses | $0.00B | $0.66B | $0.59B | $0.52B | $0.47B |
| Total Operating Expenses | $2.44B | $2.56B | $2.41B | $2.43B | $2.16B |
| Operating Income | $0.74B | $0.65B | $0.30B | $0.14B | $0.34B |
| Operating Margin %(computed) | 12.99% | 11.96% | 6.32% | 3.24% | 8.47% |
| Interest Income | $0.01B | $0.02B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.03B | $0.03B | $0.09B | $0.03B | $0.03B |
| Income Before Tax | $0.71B | $0.30B | $0.21B | $0.11B | $0.31B |
| Income Tax Expense | $0.14B | $0.07B | $0.04B | $0.02B | $0.06B |
| Net Income | $0.57B | $0.23B | $0.17B | $0.09B | $0.25B |
| Net Margin %(computed) | 10.09% | 4.36% | 3.52% | 2.09% | 6.15% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $2.15 | $0.88 | $0.64 | $0.37 | $0.98 |
| Wtd Avg Shares | 0.27B | 0.27B | 0.26B | 0.25B | 0.25B |
| EBITDA | $1.09B | $0.68B | $0.64B | $0.49B | $0.50B |
| EBITDA Margin %(computed) | 19.17% | 12.65% | 13.49% | 11.07% | 12.46% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · DKK · B
深入了解Ambu A/S
关于Ambu A/S（AMBBY）损益表
Ambu A/S（AMBBY）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，AMBBY实现营收$5.69B，毛利润$3.18B（毛利率55.98%），净利润$0.57B（净利率10.09%）。
常见问题
AMBBY · 4 问Ambu A/S（AMBBY）2025财年营收为$5.69B，同比up5.5%。
AMBBY revenueAMBBY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09